Valproate Sodium (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Valproate Sodium drug offered from Fresenius Kabi USA, LLC. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | VALPROATE SODIUM |
| SUBSTANCE NAME: | VALPROATE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-08-18 |
| END MARKETING DATE: | 0000-00-00 |
Valproate Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Valproate Sodium from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2003-08-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-494_1d860671-8a34-4ebb-8569-04721d9fc3ff |
| PRODUCT NDC: | 63323-494 |
| APPLICATION NUMBER: | ANDA076539 |
Other VALPROATE SODIUM Pharmaceutical Manufacturers / Labelers:
